Gundula Jaeger

599 total citations
12 papers, 449 citations indexed

About

Gundula Jaeger is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, Gundula Jaeger has authored 12 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Gundula Jaeger's work include Cytomegalovirus and herpesvirus research (7 papers), Herpesvirus Infections and Treatments (4 papers) and Polyomavirus and related diseases (4 papers). Gundula Jaeger is often cited by papers focused on Cytomegalovirus and herpesvirus research (7 papers), Herpesvirus Infections and Treatments (4 papers) and Polyomavirus and related diseases (4 papers). Gundula Jaeger collaborates with scholars based in Germany, China and United Kingdom. Gundula Jaeger's co-authors include Josef Mautner, Johanna Tischer, Hans‐Jochem Kolb, Dušan Prevalšek, Stefanie Tippmer, Andreas Moosmann, Wolfgang Hammerschmidt, Georg Ledderose, Iris Bigalke and Dolores J. Schendel and has published in prestigious journals such as Nature Communications, Blood and Clinical Infectious Diseases.

In The Last Decade

Gundula Jaeger

12 papers receiving 444 citations

Peers

Gundula Jaeger
Ifigeneia Tzannou United States
Louise E. Kimball United States
I. Lefaki Greece
Joanne Strussenberg United States
Andrea Siegel United States
Ifigeneia Tzannou United States
Gundula Jaeger
Citations per year, relative to Gundula Jaeger Gundula Jaeger (= 1×) peers Ifigeneia Tzannou

Countries citing papers authored by Gundula Jaeger

Since Specialization
Citations

This map shows the geographic impact of Gundula Jaeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gundula Jaeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gundula Jaeger more than expected).

Fields of papers citing papers by Gundula Jaeger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gundula Jaeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gundula Jaeger. The network helps show where Gundula Jaeger may publish in the future.

Co-authorship network of co-authors of Gundula Jaeger

This figure shows the co-authorship network connecting the top 25 collaborators of Gundula Jaeger. A scholar is included among the top collaborators of Gundula Jaeger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gundula Jaeger. Gundula Jaeger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Schober, Tilmann, Thomas Magg, Melanie Laschinger, et al.. (2017). A human immunodeficiency syndrome caused by mutations in CARMIL2. Nature Communications. 8(1). 14209–14209. 83 indexed citations
2.
Peterson, Lisa, Helmut Ostermann, Michael Fiegl, et al.. (2016). Reactivation of polyomavirus in the genitourinary tract is significantly associated with severe GvHD and oral mucositis following allogeneic stem cell transplantation. Infection. 44(4). 483–490. 14 indexed citations
3.
Osterman, Andreas, María Guadalupe Vizoso-Pinto, Jette Jung, et al.. (2013). A novel indirect immunofluorescence test for the detection of IgG and IgA antibodies for diagnosis of Hepatitis E Virus infections. Journal of Virological Methods. 191(1). 48–54. 5 indexed citations
4.
Moosmann, Andreas, Iris Bigalke, Johanna Tischer, et al.. (2010). Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. Blood. 115(14). 2960–2970. 173 indexed citations
5.
Vizoso-Pinto, María Guadalupe, Klaus-Ingmar Pfrepper, Angelika Lueking, et al.. (2010). A systematic approach for the identification of novel, serologically reactive recombinant Varicella-Zoster Virus (VZV) antigens. Virology Journal. 7(1). 165–165. 17 indexed citations
6.
Baiker, Armin, Rudolf Haase, Josef Eberle, et al.. (2010). Early detection of Varicella-Zoster Virus (VZV)-specific T-cells before seroconversion in primary varicella infection: case report. Virology Journal. 7(1). 54–54. 5 indexed citations
7.
Andrassy, Joachim, W.-D. Illner, Markus Rentsch, et al.. (2009). Leflunomide: a treatment option for ganciclovir-resistant cytomegalovirus infection after renal transplantation. Clinical Kidney Journal. 2(2). 149–151. 8 indexed citations
8.
Buhmann, Raymund, et al.. (2008). Therapeutic Nucleic Acids: A Potential Source of Resistance to Cancer, Antiviral and Immunosuppressive Therapy.. Blood. 112(11). 1614–1614. 1 indexed citations
9.
Neurohr, Claus, Patrick Huppmann, Hanno Leuchte, et al.. (2005). Human Herpesvirus 6 in Bronchalveolar Lavage Fluid after Lung Transplantation: A Risk Factor for Bronchiolitis Obliterans Syndrome?. American Journal of Transplantation. 5(12). 2982–2991. 51 indexed citations
10.
Fiegl, Michael, et al.. (2005). Recovery from CMV esophagitis after allogeneic bone marrow transplantation using non-myeloablative conditioning: The role of immunosuppression. Journal of Clinical Virology. 34(3). 219–223. 4 indexed citations
11.
Birnbaum, Tobias, C. S. Padovan, Bernd Sporer, et al.. (2005). Severe Meningoencephalitis Caused by Human Herpesvirus 6 Type B in an Immunocompetent Woman Treated with Ganciclovir. Clinical Infectious Diseases. 40(6). 887–889. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026